Medscape

New reporting indicates that dupilumab's benefits for quality of life in children vary depending on the child's age. The finding, highlighted by Medscape, suggests younger and older children may respond differently to the biologic drug, which is used for conditions such as atopic dermatitis and asthma. Clinicians may need to weigh age when considering treatment expectations.